Although the relationship between PTEN and ERBB2 has not been studied in GC, the frequency of PTEN inactivation in ERBB2-amplified GC has been reported in 16.4–34.5% of cases [36,37,38]. This evidence concerns the gene ERBB2 and gastric cancer.